SCHEMBL3264683

SCHEMBL3264683

Cc1cc(-c2cnc(N3CCOCC3)c(C(=O)O)c2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.49
CNR1 P21554 1/20 0.46
TP53 P04637 5/20 0.44
LMNA P02545 2/20 0.44
PRKAB2 O43741 1/20 0.44
PRKAG1 P54619 1/20 0.44
PRKAA2 P54646 1/20 0.44
PRKAA1 Q13131 1/20 0.44
PRKAG3 Q9UGI9 1/20 0.44
PRKAG2 Q9UGJ0 1/20 0.44
PRKAB1 Q9Y478 1/20 0.44
JAK2 O60674 1/20 0.43
THRB P10828 2/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PIK3C2B O00750 1/20 0.41
MET P08581 1/20 0.41
CYP2C9 P11712 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3264680 0.83 CNR2 (0.53) CNR2CNR1TP53LMNAPRKAB2
SCHEMBL2273526 0.81 CNR2 (0.45) CNR2CNR1TP53LMNAPRKAB2
SCHEMBL17479078 0.77 ALDH1A1 (0.42) CNR2CNR1TP53PRKAB2PRKAG1
SCHEMBL17478688 0.77 LRRK2 (0.46) CNR2
SCHEMBL17478785 0.77 GAK (0.51) CNR2CNR1TP53LMNAPRKAB2
SCHEMBL17478716 0.77 PRKAB2 (0.50) CNR2CNR1TP53LMNAPRKAB2
SCHEMBL17478815 0.76 CYP1A2 (0.52) CNR2LMNATSHR
SCHEMBL4909244 0.75 TOP2A (0.48) CNR2CNR1SMN1; SMN2
SCHEMBL17479159 0.74 CNR2 (0.40) CNR2CNR1TP53PRKAB2PRKAG1
SCHEMBL23779628 0.72 CNR2 (0.59) CNR2CNR1TP53LMNAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184981-A1 PYRIDINE CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2010-05-19 EP disclosed
WO-2009020642-A1 PYRIDINE CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2009-02-12 WO disclosed